Intellectual Property

  • April 20, 2026

    Kawasaki Asks To Double $48M Patent Win In Calif.

    Kawasaki has urged a California federal court to double the $48 million jury award it won last month in a patent infringement suit against Japanese technology company Rorze Corp., while Rorze is asking for a new trial.

  • April 20, 2026

    Akin Taps Kirkland Atty To Lead Music Team

    Akin Gump Strauss Hauer & Feld LLP announced on Monday that it has hired a former Kirkland & Ellis LLP partner to lead its music practice, touting his work at the intersection of intellectual property, media and entertainment, technology and commercial transactions.

  • April 20, 2026

    GSK, Moderna Both Ordered To Provide More Info In Vax Fight

    A special master overseeing discovery disputes in GlaxoSmithKline's infringement suits over Moderna's COVID-19 and related respiratory syncytial virus vaccines ordered both companies to furnish information to each other, including financial data and licenses, according to an opinion unsealed Monday.

  • April 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.

  • April 20, 2026

    Justices Won't Consider IP Theft Allegations Against Akin

    The U.S. Supreme Court on Monday rejected a former Cornell University graduate student's petition trying to revive his malpractice suit against Akin Gump Strauss Hauer & Feld LLP stemming from patent litigation against Illumina Inc. over DNA sequencing intellectual property.

  • April 20, 2026

    Justices Decline 'Rapunzel' Dispute Over Trademark Standing

    The U.S. Supreme Court on Monday declined to hear a law professor's trademark appeal over the name "Rapunzel," leaving intact a Federal Circuit ruling that found consumers lack standing to challenge generic marks at the U.S. Patent and Trademark Office.

  • April 20, 2026

    High Court Rejects Artist's Appeal In Walmart Copyright Feud

    The U.S. Supreme Court on Monday passed on reviewing a sculptor's efforts to save a portion of her copyright case against Walmart over photographs that appeared on its website, letting stand a Ninth Circuit decision that partly reversed her lower court win in the suit.

  • April 17, 2026

    Bayer Loses Bid To Block J&J's Cancer Drug Survival Claims

    A Manhattan federal judge Friday refused to block Johnson & Johnson from advertising its prostate cancer drug as having a lower risk of death compared with Bayer's medication, saying Bayer has not shown it is likely to succeed on its claims that its rival's advertising campaign is false or misleading.

  • April 17, 2026

    ITC Clears Apple's Redesigned Apple Watch For Import

    The U.S. International Trade Commission on Friday signed off on an administrative law judge's finding that Apple has sufficiently redesigned its smartwatch so it doesn't infringe Masimo Corp.'s patents and is therefore not bound by a 2023 import ban.

  • April 17, 2026

    11th Circ. Revives Trademark Suit Against Frida Kahlo Family

    The Eleventh Circuit on Friday agreed to resurrect a dispute between a company that claims to own various Frida Kahlo trademarks and Kahlo's family, ruling that a lower court erred in throwing out the case for lack of jurisdiction. 

  • April 17, 2026

    Polygon Says Ex-Execs Engaged In Self-Dealing

    Two former executives of artificial intelligence company Predicate Labs Inc. have been hit with a suit in Delaware Chancery Court alleging that following a $400 million acquisition of the company in 2021, the executives "began a campaign of self-dealings, intentional misrepresentation, deceptive inducement and willful breach."

  • April 17, 2026

    Impossible Foods Says No Harm Shown In $3.25M TM Loss

    Impossible Foods urged a California federal judge Thursday to reject lifestyle brand Impossible X's request to award it over $3 million in attorney fees and enhance a jury's $3.25 million verdict that found the food company willfully infringed its "Impossible" marks, saying the evidence shows no "actual harm" came from the infringement.

  • April 17, 2026

    PTAB Petitions Continue To Plummet As Reexams Surge

    The number of America Invents Act petitions continued to crater as the volume of reexamination requests skyrocketed in the first quarter of 2026 as policies by U.S. Patent and Trademark Office Director John Squires settled in, according to a new report from Unified Patents.

  • April 17, 2026

    OpenAI Drops 9th Circ. Appeal Over 'Cameo' TM Block

    OpenAI has abandoned its Ninth Circuit appeal of an injunction blocking it from using the term "Cameo" in relation to a component of its artificial intelligence video generator Sora 2.

  • April 17, 2026

    WDTX Jury Clears Bitcoin Mining Co. In Patent Suit

    A federal jury in the Western District of Texas let bitcoin mining company Riot Platforms off the hook Friday when it found the company didn't infringe a patent owned by Green Revolution Cooling Inc. covering ways to cool down electronics at data centers.

  • April 17, 2026

    Google Wins Ax Of Last Targeted Ad Patent Claim In Suit

    A Delaware federal judge has found the sole remaining claim in a targeted advertising software patent Google was accused of infringing is invalid, saying it is abstract and doesn't cover an inventive idea.

  • April 17, 2026

    Denver Food Truck Biz Says Rival Stole Secrets Via Sham Deal

    A Denver food truck business has claimed its would-be partners stole its operational playbook and then threatened its owner and employees, according to a lawsuit filed in Colorado state court.

  • April 17, 2026

    Denver Bookshop Says 'Book Society' Can't Be A Trademark

    A Denver independent bookstore asked a Colorado federal judge Friday to declare it is not infringing upon a California book and wine lounge or engaging in unfair competition by using "book society" in its name.

  • April 17, 2026

    HyperSphere Beats Tech IP Suit, Falters On Sanctions Bid

    Georgia-based cybersecurity firm HyperSphere Technologies Inc. on Friday escaped a suit alleging infringement of a developer's copyrighted software code but was denied a request for sanctions for having to defend itself from what it called a "frivolous" lawsuit.

  • April 17, 2026

    Rapper Says Coach Ripped Off 'This Is A Blue T-Shirt' Mark

    Los Angeles rapper G Perico alleges in a California federal lawsuit that luxury brand Coach has infringed his "this is a blue t-shirt" trademark and brand by selling shirts that bear the slogan "this is a Coach t-shirt."

  • April 17, 2026

    PTAB To Eye 3 Patents After Squires Rejected TikTok Reviews

    The Patent Trial and Appeal Board has agreed to launch reviews of whether three Cellspin Soft Inc. patents for publishing data on websites are invalid after the company was able to dodge earlier challenges from TikTok.

  • April 17, 2026

    Deer Feed Co. Fights Blockbuster's 'Block Buster' TM Claims

    A Mississippi animal feed company has asked federal trademark judges to throw out Blockbuster LLC's bid to block an application for "Block Buster" for deer feed supplements, arguing the defunct video rental giant failed to clearly identify which of its many registrations are allegedly being infringed or diluted.

  • April 17, 2026

    'Lion King' Suit May Not Reign In Podcasting Legal Jungle

    A recently filed suit over the alleged mischaracterization of the iconic opening chant in “The Lion King” may not hold up in court, but the case highlights the risks podcasters can face in a freewheeling and increasingly ubiquitous medium, experts say.

  • April 17, 2026

    Life Sciences Firm Says Ex-VP Took Trade Secrets To Rival

    A Massachusetts life sciences startup says a former vice president who left the company last fall, purportedly to care for his ill wife, instead took trade secrets with him to a new job at a California rival.

  • April 17, 2026

    Polsinelli Sent Bogus Infringement Letters, Suits Say

    National law firm Polsinelli PC was accused of sending letters to two medical device companies with meritless claims of patent infringement, the companies claimed in a pair of malpractice suits.

Expert Analysis

  • Learning From A Typical Section 1782 Discovery Case

    Author Photo

    A California federal judge's recent approval of a Section 1782 application, compelling a U.S.-based company to produce materials relevant to a German patent dispute, usefully illustrates the specific steps foreign litigants must undertake before wielding this powerful tool for obtaining evidence unavailable via discovery mechanisms abroad, say attorneys at Fish & Richardson.

  • How To Trademark A Guy In 8 Ways: An IP Strategy Against AI

    Author Photo

    Attempting a novel method of protection against artificial intelligence misuse of his voice and likeness, Matthew McConaughey's recent efforts to register eight trademarks for a series of audio and video clips of himself underscore the importance of extending existing legal frameworks beyond traditional applications, says Summer Todd at Patterson Intellectual Property.

  • Utilizing The ITC To Combat 'Gray Market' IP Infringement

    Author Photo

    As technological developments intensify trademark owners' need to respond swiftly to "gray market" sales of international goods imported into the U.S. without the trademark owner's consent, litigating at the U.S. International Trade Commission offers an underutilized enforcement option, say attorneys at MoFo.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

    Author Photo

    With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

  • How 2 Tech Statutes Are Being Applied To Agentic AI

    Author Photo

    The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

  • NYC Bar Opinion Warns Attys On Use Of AI Recording Tools

    Author Photo

    Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Patent Eligibility Faces Widening Gap Between USPTO, Courts

    Author Photo

    The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.